NEUP Stock Moves Higher as Traders Focus on Neuphoria’s Cash Runway
Neuphoria Therapeutics Inc. shares traded higher in midday action Wednesday. The move came as biotech stocks attracted buyers, although Neuphoria’s newest filing pointed to a focus on conserving cash and weighing options over any immediate drug revenue. The stock, which trades on Nasdaq, last changed hands at $5.00, up 23 cents. Shares opened at $4.71 and ranged from $4.77 to $5.00. Volume hit 33,745 shares on the latest trade—enough to stand out, though well below large-cap levels.